Genetic Markers Aid in Tracking CVD Risk in SSc - Two markers appear to be useful for identifying SSc patients at risk for pulmonary hypertension.

Author: Diana Swift
Date Published: January-2015
Source: MedPage Today

Patients with systemic sclerosis (SSc) who are free of traditional cardiovascular risk factors can still have increased levels of two biomarkers indicative of myocyte injury: high-sensitivity cardiac troponin (HS-cTnT) and N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP). "Elevated levels of these markers may reflect subclinical myocardial damage and dysfunction caused by the disease [SSc] itself," wrote French investigators online in Arthritis Care and Research.